Mara is an accomplished health care policy executive who provides strategic advice on a broad range of federal legislative, regulatory and policy issues, including Medicare, value-based care, digital health and other areas. Mara also assists clients in their interactions with Congress and the Administration to help advance their business and thought leadership goals.
Mara was listed on The Hill’s Top Lobbyist list for 2021. She is frequently invited to speak at premier national events and has been featured with industry leaders on discussion panels, sharing her advanced knowledge and experience on policy issues facing healthcare industry clients.
In addition to consulting and lobbying services, Mara convenes advocacy coalitions, bringing together like-minded organizations to advance shared objectives. These groups help to advance policy change by coalescing healthcare stakeholders and implementing strategic advocacy plans.
Previously, Mara served as the senior vice president of federal affairs and head of the Washington, DC office at America’s Physician Groups (formerly the California Association of Physician Groups, CAPG), a professional association representing medical groups and independent practice associations practicing in capitated, coordinated care models. Prior to that, Mara worked as an attorney in the health law practice of another large law firm, focusing on regulatory issues facing physician groups, hospitals, pharmaceutical companies, and academic medical institutions.
ACOs unsure about health equity adjustment to REACH model
Impact of Emergency Declarations on CMS Waivers
President’s FY 2023 Budget: HHS Highlights
Omnibus Spending Package Extends Select Telehealth Flexibilities
CMS ANNOUNCES REQUEST FOR APPLICATIONS FOR PARTICIPATION IN THE ACO REACH MODEL
Turmoil over Direct Contracting model has CMS mulling changes
Trump-era Medicare program under increased scrutiny
What could Direct Contracting changes look like?
Is there real value in value-based care?
Hundreds of orgs ask Congress to extend telehealth waivers through 2024
WHITE HOUSE OFFICE OF SCIENCE AND TECHNOLOGY POLICY SEEKING INFORMATION ON STRENGTHENING ...
AACOM Engages McDermottPlus to Strengthen Osteopathic Voice on Capitol Hill
At last minute, CMS gives clarity on No Surprises estimates, convening terms
Broadband internet proves a hurdle as telehealth services continue to rise in ...
Hospitals grapple with Omicron — and legal brawl over vaccinating staff
What's Next for the Value Based Care Coalition
End-Stage Renal Disease Prospective Payment System CY 2022 Rule Update
CMS Releases CY 2022 Physician Fee Schedule Final Rule
CMS Innovation Center Strategy Refresh: Policy Update
Seeking Reimbursement for AI Tech? Five Things to Remember
CMS Releases FY 2022 IPPS Final Rule
430 Organizations Urge Congress to Address ‘Telehealth Cliff’
CMS Releases CY 2022 Physician Fee Schedule Proposed Rule
President’s Fiscal Year 2022 Budget: What You Need to Know
CONNECT for Health: What it Would and Wouldn’t do for Telehealth ...
Webinar Series | Telehealth 101: An Introduction to the Medicare Telehealth Landscape
To Sustain The Value Movement, Make Next Generation ACOs A Permanent Option
Opinion: Internet Access Is a Critical Telehealth, Equity Issue
There’s No Point Person in Biden’s HHS for Its $187 Billion ...
American Rescue Plan Act of 2021: Key Healthcare Provisions
Health Policy Breakroom Ep. 55 - Welcome to the Biden Administration
After Repeated Delays, Trump’s HHS Punts on Oversight of a Massive ...
The First 100 Days: Biden's Healthcare Outlook
Summary of Key Health Provisions in the Consolidated Appropriations Act, 2021
Direct Contracting — a Pathway Forward for Healthcare Delivery Amidst COVID-19
Provider-Relief Grant-Spending Reports Due in February 2021
Rethink Medicare’s APM Incentives to Drive Value-Based Care
Show MoreDo not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
